Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Extensive Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04947774
What this trial is testing

Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Chinese Academy of Medical Sciences 100
Large-scale testing (Phase 3)UnknownNCT00168896
What this trial is testing

Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Who this might be right for
Small Cell Lung Cancer
Charite University, Berlin, Germany 286
Testing effectiveness (Phase 2)Study completedNCT02937818
What this trial is testing

A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer

Who this might be right for
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
AstraZeneca 72
Testing effectiveness (Phase 2)Looking for participantsNCT06243003
What this trial is testing

WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases

Who this might be right for
SCLC,Extensive StageBrain Metastases
Fudan University 56
Testing effectiveness (Phase 2)Ended earlyNCT01573338
What this trial is testing

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)

Who this might be right for
Small Cell Lung Carcinoma
Bayer 43
Testing effectiveness (Phase 2)Study completedNCT00104793
What this trial is testing

Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Japan Multinational Trial Organization 55
Not applicableStudy completedNCT00416689
What this trial is testing

Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer

Who this might be right for
Breast CancerLung CancerNausea and Vomiting
Alliance for Clinical Trials in Oncology 99
Testing effectiveness (Phase 2)Ended earlyNCT00084487
What this trial is testing

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Who this might be right for
Extensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 21
Early research (Phase 1)Ended earlyNCT03963414
What this trial is testing

Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLC

Who this might be right for
Small Cell Lung Carcinoma
University of Nebraska 1
Testing effectiveness (Phase 2)UnknownNCT01441349
What this trial is testing

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
National Cancer Center, Korea 192
Large-scale testing (Phase 3)Active Not RecruitingNCT04155034
What this trial is testing

S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaLung Small Cell Carcinoma
SWOG Cancer Research Network 668
Not applicableStudy completedNCT01416688
What this trial is testing

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Who this might be right for
Colorectal CancerDermatologic ComplicationsLung Cancer+1 more
SWOG Cancer Research Network 146
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Early research (Phase 1)Looking for participantsNCT06348797
What this trial is testing

Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Sichuan University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05142696
What this trial is testing

[177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Novartis Pharmaceuticals 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728230
What this trial is testing

Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)UnknownNCT05975944
What this trial is testing

Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 49
Testing effectiveness (Phase 2)UnknownNCT03841136
What this trial is testing

Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Fudan University 70
Testing effectiveness (Phase 2)Study completedNCT05309629
What this trial is testing

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06768307
What this trial is testing

Assessment of Adebelizumab Combined With Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageImmunotherapyChemotherapy+1 more
Peking University Cancer Hospital & Institute 60
Next Page